Table 4.
Pulmonary disorders associated with genetic intervention of autophagy in mice.
Setting | Genetic intervention | Effects on disease phenotype | Ref. |
---|---|---|---|
COPD | Whole‐body deletion of Map1 lc3b | Decreased signs of emphysema and resistance to cilia shortening after CS exposure | Chen et al (2010), Lam et al (2013) |
COPD | Whole‐body allelic loss of Becn1 | Resistance to cilia shortening after CS exposure | Lam et al (2013) |
COPD | X chromosome deletion of Hdac6 | Resistance to cilia shortening after CS exposure | Lam et al (2013) |
COPD | Whole‐body deletion of miR‐21 | Improved pulmonary fitness after CS exposure by reducing autophagy activation in bronchiolar cells | Zeng et al (2018) |
COPD | Whole‐body deletion of Pink1 | Improved lung function after subchronic CS exposure, linked to impaired mitophagy | Mizumura et al (2014) |
Pulmonary fibrosis | Whole‐body deletion of Atg4b | Exacerbated bleomycin‐induced lung injury linked to increased lung inflammation | Cabrera et al (2015) |
Pulmonary fibrosis | Conditional AEC‐specific deletion of Tsc1 | Exacerbated bleomycin‐induced lung injury after mTORC1 overactivation | Gui et al (2015) |
Pulmonary fibrosis | Conditional A2T progenitor cell‐specific deletion of Atg5 | Exacerbated bleomycin‐induced lung injury by reducing A2T stemness | Li et al (2020a) |
Pulmonary fibrosis | Whole‐body deletion of Anxa2 | Mitigated bleomycin‐induced lung injury via TFEB‐mediated autophagy activation | Wang et al (2018a) |
Pulmonary fibrosis | Whole‐body deletion of Tlr4 | Exacerbated bleomycin‐induced lung injury and pulmonary inflammation after autophagy inhibition | Yang et al (2012) |
Pulmonary fibrosis | Conditional myeloid cell‐specific deletion of Atg5 or Atg7 | Exacerbated bleomycin‐induced fibrosis and spontaneous lung inflammation by enhancing inflammasome activation | Abdel Fattah et al (2015), Jessop et al (2016) |
Pulmonary fibrosis | Whole‐body deletion of Pink1 | Accelerated development of bleomycin‐induced lung fibrosis linked to accumulation of dysfunctional mitochondria in AEC cells | Bueno et al (2015) |
Pulmonary fibrosis | Whole‐body deletion of Prkn | Accelerated development of bleomycin‐induced lung fibrosis after mitophagy inhibition | Kobayashi et al (2016) |
Sarcoidosis | Conditional myeloid cell‐specific deletion of Tsc2 | Exacerbated granuloma formation after mTORC1‐mediated hypertrophy and proliferation in macrophages | Linke et al (2017) |
Cystic fibrosis | CFTRdel506 transgenic mice | Impaired autophagy through TG2‐mediated BECN1 inhibition | Luciani et al (2010) |
AEC, alveolar epithelial cell; A2T, alveolar type 2; COPD, chronic obstructive pulmonary disease, CS, cigarette smoke.